Adefovir is an antiviral agent (acyclic nucleotide), formerly an investigational drug, has been withdrawn from the investigational program. The manufacturer, Gilead, is not pursuing FDA-approval. Oral adefovir dipivoxil has shown efficacy in chronic hepatitis B infection and HIV infection in limited studies. Adefovir may also prove useful for preventing or treating opportunistic herpes virus infections in HIV-infected patients.
This drug should NOT be coded